Amisha Patel

Amisha Patel has over 11 years of work experience in the pharmaceutical industry. In 2009, they began their career as a Lab Analyst at Clinical Trials Laboratory Services, where they worked in compliance with GCP and GLP guidelines and successfully performed method development on a product using HPLC-UV and extraction of samples using gel electrophoresis. In 2010, they moved to GlaxoSmithKline as a Bio Analyst, where they validated bioanalytical methods and the analysis of study samples for clinical trials/non-clinical trials following GCP/GLP guidelines, and performed bio-analytical method validation using UPLC-MS. In 2011, they joined RB as an R&D Lemsip Analyst, where they conducted stability sample and release analysis of already existing products (long term, intermediate and accelerated stability study) on range of Lemsip products. In 2012, they moved to Quotient Bioresearch as a Senior Analytical Chemist and an Anaytical Chemist, where they custom analyzed radiolabelled compounds (API's) for use by the pharmaceutical industry in pre-clinical dosimetry studies and clinical studies, and performed ID testing and QC release of raw materials, chemicals and API from to the GMP standards. In 2018, they joined BPL therapeutics as a QA Ops Shift Team Leader, where they took ownership on all aspects of QA activities relating to the production and QA review of BPL Products, and ensured compliance with all applicable (EHS and GxP) regulatory and internal quality standards and industry best practice. In 2019, they moved to Lonza as a QA Operations team leader, and in 2021, they joined Ori Biotech as a Quality Manager.

Amisha Patel completed their Master's Degree in Pharmaceutical Analysis with Management Studies at Kingston University from 2008 to 2009. Prior to that, they obtained their Bachelor's Degree in Pharmacy from South Gujarat University from 2004 to 2008.